NASDAQ:AMPH
Amphastar Pharmaceuticals Stock News
$41.11
+0.280 (+0.686%)
At Close: Apr 26, 2024
3 Generic Drug Stocks to Watch Amid Continued Pricing Pressure
02:54pm, Monday, 02'nd May 2022 Zacks Investment Research
The impact of COVID-19 and continued pricing pressure on the Zacks Medical-Generic Drugs industry remains. New product launches may provide some respite for BHC, AMPH and SLGL.
3 Generic Drug Stocks to Watch Amid Continued Pricing Pressure
12:02pm, Monday, 02'nd May 2022
The impact of COVID-19 and continued pricing pressure on the Zacks Medical-Generic Drugs industry remains. New product launches may provide some respite for BHC, AMPH and SLGL.
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy?
07:02pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Amphastar (AMPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy?
04:35pm, Thursday, 28'th Apr 2022
Amphastar (AMPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Amphastar (AMPH) Keep the Earnings Surprise Streak Alive?
04:10pm, Friday, 22'nd Apr 2022 Zacks Investment Research
Amphastar (AMPH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Can Amphastar (AMPH) Keep the Earnings Surprise Streak Alive?
01:32pm, Friday, 22'nd Apr 2022
Amphastar (AMPH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
10 Stocks That Have Moved Over 20% Since The Indices Plummeted
06:49pm, Friday, 08'th Apr 2022 Benzinga
The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
The S&P fell by 14.
10 Stocks That Have Moved Over 20% Since The Indices Lost Over 12%!
02:51pm, Friday, 08'th Apr 2022
The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
Amphastar Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
04:10pm, Wednesday, 06'th Apr 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 6, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communication
These 2 Nasdaq Stocks Hit All-Time Highs Wednesday
06:12pm, Wednesday, 23'rd Mar 2022 The Motley Fool
Even in a tough market, one large-cap company and a small-cap rising star are beating the odds.
7 “A”-Rated Stocks to Ground Your Portfolio
01:40pm, Thursday, 17'th Mar 2022
It's a good time to make sure you have "A"-rated stocks in your portfolio. Many of the ones here have my triple-"A" rating.
Amphastar climbs after Q4 beat as Piper Sandler raises target to a Street high
04:41pm, Friday, 11'th Mar 2022 Seeking Alpha
The shares of the generic drugmaker, Amphastar Pharmaceuticals <>, have recorded the sharpest intraday gain in nearly two years on Friday as investors react to the…
Amphastar Pharmaceuticals (AMPH) Q4 2021 Earnings Call Transcript
03:00am, Friday, 11'th Mar 2022 The Motley Fool
AMPH earnings call for the period ending December 31, 2021.
Amphastar Pharmaceuticals (AMPH) Q4 2021 Earnings Call Transcript
03:00am, Friday, 11'th Mar 2022 The Motley Fool
AMPH earnings call for the period ending December 31, 2021.
